ParamergeParamerge

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

National Cancer Institute (NIH)

Funds investigator-initiated clinical trials in cancer prevention and control covering early detection, screening, prevention, healthcare delivery, quality of life and survivorship. Trials of cancer diagnosis or oncologic therapy are explicitly excluded.

Indicative award
Not a cash award (not a cash award)Page states application budgets are not limited but must reflect actual project needs; maximum project period 5 years. No dollar figure published.
Timing
Several times a yearSeveral times a year · Feb, Jun, OctNo specific published date recorded. This funder publishes a cycle rather than a date, and this database does not invent one.Standard NIH February 5 / June 5 / October 5 cycle; the dates enumerated on the page run through February 5, 2026 and the NOFO expires January 8, 2027. No specific future date is asserted here.
Who can apply
Early-career faculty, Mid-career & senior, Any faculty rank
Eligibility
Public and private higher education institutions, nonprofits with or without 501(c)(3) status, for-profits and small businesses, state/county/local and federally recognised tribal governments, faith-based and community-based organisations, and foreign organisations. SAM, eRA Commons and Grants.gov registration required; the project must be an NIH-defined clinical trial.
SSWR clusters
Topics
cancer prevention · survivorship · quality of life · screening · health care delivery
Apply at
https://grants.nih.gov/grants/guide/pa-files/PAR-25-167.html
This entry
Curated by the working group. Written 2026-08-07. The funder link has not yet been machine-checked.

Amounts and dates on this page are indicative and are maintained by people rather than scraped. Funders change ceilings, windows and eligibility without notice; confirm all details at the source above before applying.

← Back to the database